We are live on
!
Find out more
SGAM
Smith Group Asset Management Portfolio holdings
AUM
$2.46B
Turnover
25.53%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.46B
AUM Growth
+$46.3M
(+1.4%)
Cap. Flow
-$206M
Cap. Flow
% of AUM
-5.95%
Top 10 Holdings %
Top 10 Hldgs %
24.55%
Holding
500
New
53
Increased
40
Reduced
235
Closed
55
Avg Time Held
1.5
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$68.5M |
| 2 |
Ross Stores
ROST
|
+$43.1M |
| 3 |
Vistance Networks Inc
VISN
|
+$40.4M |
| 4 |
TD Ameritrade Holding Corp
AMTD
|
+$34.5M |
| 5 |
Hershey
HSY
|
+$33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$73.4M |
| 2 |
RHT
Red Hat Inc
RHT
|
+$66.7M |
| 3 |
IQVIA
IQV
|
+$58.8M |
| 4 |
Target
TGT
|
+$56M |
| 5 |
CLGX
Corelogic, Inc.
CLGX
|
+$40.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.76% |
| 2 | Consumer Discretionary | 17.48% |
| 3 | Healthcare | 16.31% |
| 4 | Industrials | 13.3% |
| 5 | Communication Services | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ALDR
251
DELISTED
Alder Biopharmaceuticals
ALDR
| $224K | 0.01% |
10,760
| – | – |
2016 Q2
3 quarters
|
|
|
FNHC
252
DELISTED
FedNat Holding Company Common Stock
FNHC
| $222K | 0.01% |
+12,750
| New | +$243K |
2017 Q1
0 quarters
|
|
253
RELX
RELX
$67.8B
| $221K | 0.01% |
11,172
-400
| -3% | -$7.47K |
2014 Q4
9 quarters
|
|
254
New Oriental
EDU
$9.44B
| $220K | 0.01% |
3,650
-100
| -3% | -$5.07K |
2016 Q1
4 quarters
|
|
255
Restaurant Brands International
QSR
$26.1B
| $220K | 0.01% |
3,954
-200
| -5% | -$10.5K |
2016 Q3
2 quarters
|
|
256
BP
BP
$129B
| $218K | 0.01% |
7,228
+6,668
| +1,191% | +$203K |
2016 Q4
1 quarter
|
|
|
TOWR
257
DELISTED
Tower International, Inc.
TOWR
| $217K | 0.01% |
8,010
-105,600
| -93% | -$2.87M |
2013 Q2
15 quarters
|
|
258
Royal Bank of Canada
RY
$274B
| $214K | 0.01% |
2,941
-100
| -3% | -$7.25K |
2014 Q2
11 quarters
|
|
259
Canadian Imperial Bank of Commerce
CM
$102B
| $213K | 0.01% |
4,940
-200
| -4% | -$8.69K |
2016 Q3
2 quarters
|
|
|
ABB
260
DELISTED
ABB Ltd
ABB
| $211K | 0.01% |
8,996
-300
| -3% | -$6.86K |
2016 Q2
3 quarters
|
|
|
RDS.B
261
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $211K | 0.01% |
3,793
+2,162
| +133% | +$123K |
2013 Q2
15 quarters
|
|
262
WPP
WPP
$5.88B
| $210K | 0.01% |
1,919
-100
| -5% | -$11.2K |
2016 Q4
1 quarter
|
|
263
Puma Biotechnology
PBYI
$507M
| $206K | 0.01% |
5,540
| – | – |
2016 Q3
2 quarters
|
|
264
JOYY Inc
JOYY
$4.05B
| $206K | 0.01% |
+4,461
| New | +$198K |
2017 Q1
0 quarters
|
|
265
Sumitomo Mitsui Financial Group, Inc American Depositary Shares (each representing 1.2 shares of Common Stock)
SMFG
$155B
| $203K | 0.01% |
27,943
-1,100
| -4% | -$8.54K |
2013 Q2
15 quarters
|
|
266
Grupo Aeroportuario Centro Norte
OMAB
$4.43B
| $202K | 0.01% |
4,685
-200
| -4% | -$7.41K |
2013 Q3
14 quarters
|
|
267
DELISTED
Unilever NV New York Registry Shares
UN
| $199K | 0.01% |
4,015
-200
| -5% | -$8.96K |
2015 Q1
8 quarters
|
|
268
Toronto Dominion Bank
TD
$197B
| $197K | 0.01% |
+3,940
| New | +$201K |
2017 Q1
0 quarters
|
|
269
Accenture
ACN
$141B
| $194K | 0.01% |
1,618
-100
| -6% | -$11.9K |
2016 Q4
1 quarter
|
|
270
Manulife Financial
MFC
$73.4B
| $192K | 0.01% |
+10,815
| New | +$199K |
2017 Q1
0 quarters
|
|
|
SHI
271
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
| $186K | 0.01% |
3,335
-1,108
| -25% | -$66.2K |
2016 Q1
4 quarters
|
|
272
Anika Therapeutics
ANIK
$267M
| $184K | 0.01% |
4,230
-2,030
| -32% | -$96.9K |
2013 Q2
15 quarters
|
|
|
SGYP
273
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $184K | 0.01% |
+39,550
| New | +$229K |
2017 Q1
0 quarters
|
|
274
GSK
GSK
$99.2B
| $183K | 0.01% |
3,477
-160
| -4% | -$8.12K |
2016 Q1
4 quarters
|
|
|
DCM
275
DELISTED
NTT DOCOMO, Inc.
DCM
| $177K | 0.01% |
7,580
-300
| -4% | -$7.14K |
2015 Q3
6 quarters
|
|
Similar funds
MAMU
PC
RG
DIA
Smith Group Asset Management's Q1 2017 Portfolio in Review
As of Q1 2017, Smith Group Asset Management held 500 positions worth $3.46B, up 1.4% from $3.42B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Smith Group Asset Management withdrew a net $206M in Q1 2017, closing 55 positions and reducing 235 holdings. Its most notable exit was Red Hat Inc, an estimated $66.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Smith Group Asset Management opened a new position in Celgene Corp worth $71.3M.
- Smith Group Asset Management's largest Q1 2017 buy was Celgene Corp: 572,792 shares worth $71.3M.
- Smith Group Asset Management added most to US Bancorp in Q1 2017, an estimated $22.7M increase.
- Smith Group Asset Management's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $73.4M.
- Smith Group Asset Management fully exited Red Hat Inc in Q1 2017, selling an estimated $66.7M.
- Smith Group Asset Management's ten largest holdings make up 25% of its $3.46B portfolio in Q1 2017.
- Smith Group Asset Management opened 53 new positions and closed 55 in Q1 2017.
- Smith Group Asset Management's portfolio value rose 1.4% quarter-over-quarter to $3.46B.
Based on Smith Group Asset Management's 13F filing for Q1 2017, filed 4 May 2017.